Showing results (411-420 of 1,393) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|September 11, 2020
Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast InitiativeChristian Brueffer, Johan Vallon-Christersson, Dorthe Grabau, et al.JCO Precision Oncology|September 11, 2020
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown PrimaryRoger Olofsson Bagge, Akif Demir, Joakim Karlsson, et al.JCO Precision Oncology|September 11, 2020
Whole-Genome and Whole-Exome Sequencing in Pediatric Oncology: An Assessment of Parent and Young Adult Patient Knowledge, Attitudes, and ExpectationsJennifer A Oberg, Jenny Ruiz, Trisha Ali-Shaw, et al.JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.JCO Precision Oncology|September 11, 2020
Oncologists' Use of Genomic Sequencing Data to Inform Clinical ManagementMichele C Gornick, Erin Cobain, Lan Q Le, et al.JCO Precision Oncology|September 11, 2020
Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair DefectsEvan S Smith, Arnaud Da Cruz Paula, Karen A Cadoo, et al.JCO Precision Oncology|September 11, 2020
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical OutcomeSebastian Lundgren, Sofie Olsson Hau, Jacob Elebro, et al.JCO Precision Oncology|September 11, 2020
Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate CancerSimpa S Salami, Jeremy B Kaplan, Srinivas Nallandhighal, et al.JCO Precision Oncology|September 11, 2020
CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology GroupLata Chauhan, Miyoung Shin, Yi-Cheng Wang, et al.JCO Precision Oncology|September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal CancerBenny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.Pageof 140